The Patent Finder

Methods and Compositions for the Prevention and Treatment Neuropathy

Stealth Biotherapeutics Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/US2013/034647, filed Mar 29, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,279,008Methods and Compositions for Increasing the Dose of a Chemotherapeutic Agent
In force
 · High confidence
UsedRemaining
Stealth Biotherapeutics Inc.In forceHigh confidence
US 10,646,539Methods and Compositions for the Treatment of Neuropathy and Hyperalgesia
In force
 · High confidence
Stealth Biotherapeutics Inc.In forceHigh confidence
US 11,998,585Methods and Compositions for Increasing the Dose of a Chemotherapeutic Agent
In force
 · High confidence
Stealth Biotherapeutics Inc.In forceHigh confidence
US 9,636,378Methods and Compositions for the Prevention and Treatment Neuropathy
In force
 · High confidence
Stealth Biotherapeutics Inc.In forceHigh confidence
Application 16/842,040Methods and Compositions for the Prevention and Treatment Neuropathy
Abandoned
Abandoned Mar 10, 2022
Stealth Biotherapeutics Inc.AbandonedAbandoned Mar 10, 2022
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Stealth Biotherapeutics Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited